Articles Referencing AVEO

Negative Opinion on AVEO/ALPMY Candidate - Analyst Blog

5/3/2013, 5:30 pm from Zacks.com in Investing, Business, Stocks

AVEO Pharmaceuticals Inc. ( AVEO ) and partner Astellas Pharma, Inc. ( ALPMY ) recently received disappointing news from the US Food and Drug Administration (FDA) as its Oncologic Drugs... Read >>

Pre-Market Most Active for Apr 30, 2013 : SIRI, MTU, SMFG, PFE, DCM, NTT, STM, NUAN, VOD, ANAD, AVEO, BBRY

4/30/2013, 8:39 am from NASDAQ.com News in News Headlines, Pre-market Most Active

The NASDAQ 100 Pre-Market Indicator is up 1.74 to 2,868.69. The total Pre-Market volume is currently 18,599,782 shares traded. The following are the most active stocks for the pre-market... Read >>

Why AVEO Pharmaceuticals' Tivozanib Will Be Approved For The Treatment Of Advanced Renal Cell Carcinoma

3/20/2013, 1:11 pm from SeekingAlpha in Investing, Stocks

By Robert Schwartz : AVEO Pharmaceuticals ( AVEO ) was founded as Genpath Pharmaceuticals in 2001 in Cambridge, Massachusetts. The company engages in the discovery and development of... Read >>

Panel to Review AVEO/ALPMY's Drug - Analyst Blog

3/6/2013, 5:55 pm from Zacks.com in Investing, Business, Stocks

AVEO Pharmaceuticals, Inc. ( AVEO ) and Astellas Pharma, Inc. ( ALPMY ) recently announced that the US Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC)... Read >>

Data on AVEO/ALPMY's Tivozanib - Analyst Blog

2/13/2013, 4:30 pm from Zacks.com in Investing, Business, Stocks

AVEO Pharmaceuticals, Inc. ( AVEO ) and Astellas Pharma, Inc. ( ALPMY ) recently announced final overall survival (OS) results from the phase III TIVO-1 study on tivozanib. The TIVO-1... Read >>

Weekly CEO Buys Highlight: AVEO, ZAZA, TUES, TUES, FRAN, AKVA

12/16/2012, 11:39 am from GuruFocus in Investing

According to GuruFocus Insider Data , these are the largest CEO buys during the past week. The overall trend of CEOs is illustrated in the chart below: AVEO Pharmaceuticals Inc. ( AVEO... Read >>

Are Analysts Too Optimistic About These Stocks? Short Sellers Think So

9/12/2011, 4:50 pm from Kapitall in Investing, Investing Ideas, Stocks

(Article by Becca Lipman.   List compiled by Eben Esterhuizen, CFA. Analyst data sourced from Reuters, Short seller data sourced from Fidelity.) Analysts have by-and-large refused to... Read >>

2 Picks from an Investment Pro with 20% Annual Gains

2/22/2011, 1:00 pm from David Sterman in Investing, Basics, Investing Ideas

The stock market has seen plenty of ups and downs in the past 25 years. Through it all, hedge fund Baupost Group's Seth Klarman has managed to stay on the right side of the ledger, racking up... Read >>

The Top 12 IPOs of 2010 -- Can They Go Higher?

10/19/2010, 5:22 pm from David Sterman in Investing, Investing Ideas

The IPO market has been fairly quiet in 2010, with less than 100 deals coming through the transom. In the boom years, we'd routinely greet 300 or 400 new companies into the public market... Read >>